Announcements
Projects
Orgs
Project
Articles 39
Votes 0
FDA.gov

Authors 5

Office of the Commissioner
Office of Regulatory Affairs
Human Foods Program
Office of Inspections
Investigations
MediNatura New Mexico, Inc. Expands Voluntary Nationwide Recall of ReBoost Nasal Spray and to include ClearLife Allergy Nasal Spray Due to Microbial Contamination - fda.gov
5d
FDA Eliminates Major Barrier to Using Real-World Evidence in Drug and Device Application Reviews - fda.gov
6d
FDA Proposes Expanding Sunscreen Active Ingredient List - fda.gov
11d
FDA Approves Gene Therapy for Treatment of Spinal Muscular Atrophy - fda.gov
27d
FDA Moves to Accelerate Biosimilar Development and Lower Drug Costs - fda.gov
~2mo
Organizations Removing Petroleum Based Food Dyes from Their Products - fda.gov
4mo
FDA Recommends Removal of Voluntary Hold for Elevidys for Ambulatory Patients - fda.gov
5mo
FDA Embraces Radical Transparency by Publishing Complete Response Letters - fda.gov
5mo
FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease - FDA.gov
~2y
FDA Approves First Therapy for Rare Type of Non-Cancerous Tumors - FDA.gov
~2y
FDA Approves First Vaccine to Prevent Disease Caused by Chikungunya Virus - FDA.gov
~2y
FDA Approves Interchangeable Biosimilar for Multiple Inflammatory Diseases - FDA.gov
~2y
FDA Raises Concerns About Probiotic Products Sold for Use in Hospitalized Preterm Infants - FDA.gov
~2y
FDA Establishes New Advisory Committee on Digital Health Technologies - FDA.gov
~2y
FDA Takes Steps to Advance the Development of Novel Therapies for Stimulant Use Disorders - FDA.gov
~2y
FDA Grants First Marketing Authorization for a DNA Test to Assess Predisposition for Dozens of Cancer Types - FDA.gov
~2y
FDA Launches Pilot Program to Help Further Accelerate Development of Rare Disease Therapies - FDA.gov
~2y
FDA Approves First Biosimilar to Treat Multiple Sclerosis - FDA.gov
>2y
FDA Names First Deputy Commissioner for Proposed, Unified Human Foods Program - FDA.gov
>2y
FDA Approves First Oral Treatment for Postpartum Depression - FDA.gov
>2y
FDA Approves Second Over-the-Counter Naloxone Nasal Spray Product - FDA.gov
>2y
FDA Approves New Drug to Prevent RSV in Babies and Toddlers - FDA.gov
>2y
FDA Approves First Nonprescription Daily Oral Contraceptive - FDA.gov
>2y
FDA Converts Novel Alzheimer's Disease Treatment to Traditional Approval - FDA.gov
>2y
Recall of Everest Brand Sambhar Masala and Garam Masala in the U.S. Due to Possible Health Risk - FDA.gov
>2y